+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lacosamide Injection Market - Global Forecast 2026-2032- Product Image
Lacosamide Injection Market - Global Forecast 2026-2032- Product Image
Sale

Lacosamide Injection Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6139693
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lacosamide Injection Market is projected to reach USD 6.32 Billion in 2026. It is expected to continue growing at a CAGR of 5.36%, reaching USD 8.64 Billion by 2032.

Lacosamide Injection: Executive Overview

Lacosamide injection is an intravenous formulation used when oral administration of lacosamide is temporarily unsuitable, particularly in hospital-based seizure management. Its relevance is shaped by clinical protocols, emergency access, formulary decisions, supply reliability, and requirements for monitored administration. Assessment should therefore focus on treatment pathways, institutional procurement, regulatory status, and evidence-supported use rather than on standalone product attributes.

Hospital Care Is Reshaping Injectable Seizure Management

Key shifts include greater emphasis on rapid transition between intravenous and oral therapy, standardized seizure protocols, medication-safety controls, and continuity of supply. Hospitals are also prioritizing stewardship, appropriate patient selection, electronic prescribing safeguards, and coordinated pharmacy-neurology workflows. These changes increase the importance of dependable distribution, clear dosing guidance, and integration with broader inpatient care pathways.

Artificial Intelligence Supports Safer, More Responsive Care Pathways

Artificial intelligence can assist with seizure-risk identification, clinical documentation, medication reconciliation, demand planning, and detection of prescribing anomalies. Its practical value depends on validated datasets, transparent decision support, clinician oversight, and compliance with privacy and medical-device requirements. AI should augment-not replace-specialist judgment, particularly where intravenous therapy requires assessment of cardiac history, concomitant medicines, and patient-specific risk factors.

Regional Insights: Access Depends on Hospital Infrastructure and Regulation

North America is characterized by mature hospital formularies, structured reimbursement processes, and strong medication-safety governance. Europe combines coordinated national or regional health systems with differing procurement and reimbursement rules. Asia-Pacific presents varied access conditions, from advanced tertiary-care networks to settings where specialist coverage and cold-chain or hospital pharmacy capacity require strengthening. Latin America’s adoption is influenced by public procurement, budget discipline, and uneven specialist access. The Middle East shows concentration of advanced care in major urban hospitals alongside differing national registration pathways. Africa requires attention to essential-medicine procurement, reliable distribution, diagnostic capacity, and availability of trained neurological care teams.

Group Insights: Market Access Varies Across Multilateral Blocs

ASEAN markets differ in regulatory maturity, hospital purchasing structures, and specialist availability, making local registration and distributor capabilities important. BRICS countries reflect substantial variation in domestic manufacturing, public-sector procurement, and tertiary-care capacity. The European Union benefits from shared scientific and regulatory frameworks while retaining national reimbursement and purchasing decisions. G7 systems generally emphasize evidence-based formulary review, pharmacovigilance, and integrated hospital care. GCC countries often combine centralized procurement with advanced referral hospitals. NATO members span diverse health systems, so defense and civilian-care considerations should not obscure the primary importance of national clinical and regulatory requirements.

Country Insights: Local Protocols and Procurement Shape Uptake

Australia and Canada rely heavily on hospital formularies, specialist networks, and public health procurement. Brazil, Mexico, India, and Russia show varied public-private access, regulatory processes, and regional disparities in neurological care. China and South Korea combine expanding hospital capabilities with country-specific registration, reimbursement, and procurement considerations. Japan emphasizes formal clinical governance and hospital pharmacy controls. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated European care environments, but reimbursement, tendering, and institutional protocols differ by country. Across the United States, access is strongly influenced by hospital formularies, payer policy, emergency-care workflows, and medication-safety standards.

Priorities for Leaders: Strengthen Evidence, Access, and Supply Resilience

Industry leaders should maintain rigorous regulatory and pharmacovigilance programs, align clinical materials with approved use, and support education on intravenous-to-oral transitions and administration safeguards. They should map country-specific reimbursement and procurement routes, build resilient multi-source supply plans, and monitor hospital-level formulary decisions. Responsible AI adoption requires validated tools, clear accountability, cybersecurity controls, and measurable clinical outcomes. Partnerships with health systems should prioritize appropriate use, equitable access, and transparent evidence generation.

Research Methodology: Evidence-Led, Geography-Specific Assessment

This executive summary uses a structured review framework centered on the clinical role of lacosamide injection, hospital treatment pathways, regulatory and procurement considerations, medication safety, and health-system capacity. Regional, group, and country perspectives are interpreted through publicly verifiable health-system characteristics and jurisdictional differences. Conclusions are qualitative and intentionally exclude market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Hospital Integration Will Define Sustainable Use

The position of lacosamide injection depends on how effectively health systems integrate intravenous seizure management into safe, evidence-based hospital pathways. Durable progress will require reliable supply, appropriate patient selection, specialist oversight, consistent transition planning, and locally informed access strategies. Leaders that combine regulatory discipline, clinical education, resilient procurement, and responsible digital support will be better positioned to improve care quality across diverse health systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of rapid intravenous lacosamide infusion protocols in emergency care settings
5.2. Increasing investment in developing ready-to-use lacosamide injection formulations for hospital pharmacies
5.3. Growing focus on pharmacoeconomic analyses to support lacosamide injection reimbursement decisions
5.4. Advancements in continuous infusion technologies to optimize lacosamide delivery in critical care units
5.5. Expanding clinical trials investigating lacosamide injection use in acute stroke-induced seizure management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lacosamide Injection Market, by Indication
8.1. Introduction
8.2. Generalized Tonic Clonic Seizures
8.3. Partial Onset Seizures
9. Lacosamide Injection Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Private Hospital Pharmacy
9.2.2. Public Hospital Pharmacy
9.3. Online Pharmacy
9.3.1. E-Commerce Platforms
9.3.2. Pharmacy Portals
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. Lacosamide Injection Market, by End Use
10.1. Introduction
10.2. Clinics
10.2.1. General Clinics
10.2.2. Specialty Clinics
10.3. Home Healthcare
10.3.1. Nurse Assisted
10.3.2. Self Administration
10.4. Hospitals
10.4.1. Acute Care
10.4.2. Long Term Care
11. Lacosamide Injection Market, by Therapy Type
11.1. Introduction
11.2. Adjunctive Therapy
11.3. Monotherapy
12. Lacosamide Injection Market, by Strength
12.1. Introduction
12.2. 10 Mg/Ml
12.3. 25 Mg/Ml
13. Lacosamide Injection Market, by Packaging Type
13.1. Introduction
13.2. Multi Dose Vial
13.3. Single Dose Vial
14. Americas Lacosamide Injection Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Lacosamide Injection Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Lacosamide Injection Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. UCB Pharma S.A.
17.3.2. Sun Pharmaceutical Industries Limited
17.3.3. Cipla Limited
17.3.4. Viatris Inc.
17.3.5. Teva Pharmaceutical Industries Limited
17.3.6. Dr. Reddy’s Laboratories Limited
17.3.7. Intas Pharmaceuticals Limited
17.3.8. Torrent Pharmaceuticals Limited
17.3.9. Zydus Lifesciences Limited
17.3.10. Sandoz International GmbH
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. LACOSAMIDE INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LACOSAMIDE INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LACOSAMIDE INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LACOSAMIDE INJECTION MARKET: RESEARCHAI
FIGURE 28. LACOSAMIDE INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 29. LACOSAMIDE INJECTION MARKET: RESEARCHCONTACTS
FIGURE 30. LACOSAMIDE INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LACOSAMIDE INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY GENERALIZED TONIC CLONIC SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY GENERALIZED TONIC CLONIC SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PARTIAL ONSET SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PARTIAL ONSET SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PHARMACY PORTALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PHARMACY PORTALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY NURSE ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY NURSE ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ACUTE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ACUTE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY LONG TERM CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY LONG TERM CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ADJUNCTIVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY ADJUNCTIVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY MONOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY 10 MG/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY 10 MG/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY 25 MG/ML, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY 25 MG/ML, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LACOSAMIDE INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LACOSAMIDE INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 148. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 149. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 152. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 153. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 158. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 159. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 160. CANADA LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 294. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 295. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 303. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 304. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 305. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 306. GERMANY LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 316. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 317. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 318. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 319. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 320. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 321. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 322. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 324. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 325. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 326. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 327. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 328. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 329. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 330. FRANCE LACOSAMIDE INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA LACOSAMIDE INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA LACOSAMIDE INJECTION MARKET SIZE, BY DISTRIBUTION CH

Companies Mentioned

  • Cipla Limited
  • Dr. Reddy’s Laboratories Limited
  • Intas Pharmaceuticals Limited
  • Porton Pharma Solutions Ltd.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Torrent Pharmaceuticals Limited
  • UCB Pharma S.A.
  • Viatris Inc.
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Lacosamide Drugs Market - Global Forecast 2026-2032 - Product Image

Lacosamide Drugs Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Diazapam Injection Market - Global Forecast 2026-2032 - Product Image

Diazapam Injection Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Paclitaxel Injection Market Report 2026 - Product Image

Paclitaxel Injection Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Paclitaxel Injection - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Paclitaxel Injection - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Osteoarthritis Injectable Market Size, Share & Trends Analysis Report by Injection Type, Anatomy, End Use, and Growth Forecasts, 2026-2033 - Product Image

Osteoarthritis Injectable Market Size, Share & Trends Analysis Report by Injection Type, Anatomy, End Use, and Growth Forecasts, 2026-2033

  • Report
  • 137 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.